Search Within

Katia Ventura

Formats
  1. Meeting Abstract (13)
  2. Journal Article (10)
  3. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (24)
  2. Department of Medicine (20)
  3. Solid Tumor Oncology Division (20)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  5. Thoracic Oncology (12)
  6. GSK Faculty (11)

More Groups

People
  1. Edi Brogi (12)
  2. Francis Bodd (9)
  3. Hannah Wen (9)
  4. William Travis (9)
  5. Larry Norton (8)
  6. Jacklynn Egger (7)

More People

Years
  1. 2023 (2)
  2. 2022 (11)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (8)
Publications
  1. Modern Pathology (8)
  2. Laboratory Investigation (6)
  3. American Journal of Surgical Pathology (1)
  4. Archives of Pathology & Laboratory Medicine (1)
  5. Breast Cancer Research and Treatment (1)
  6. Breast Journal (1)

More Publications

Publishers
  1. Nature Research (9)
  2. Nature Publishing Group (6)
  3. Biomed Central Ltd (2)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio <2, HER2 copy number ≥ 4 and <6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Core needle biopsy diagnosis of fibroepithelial lesions: Features predictive of upgrade to phyllodes tumor at excision
    Meeting Abstract

    Salagean, E.; Ventura, K.; Brogi, E.; Murray, M.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save